Key result
Continuous intracardiac ST monitoring via ICD failed to provide clinical benefit over conventional ICDs and increased unscheduled outpatient visits.
Why the study?
Does continuous intracardiac ST-segment monitoring via ICD improve clinical outcomes or patient management in patients with coronary artery disease?
Observational (n=103)
No
Does continuous intracardiac ST-segment monitoring via ICD improve clinical outcomes or patient management in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
Continuous intracardiac ST-segment monitoring via ICD did not provide clinical benefit and increased unscheduled evaluations due to false-positive alerts in patients with coronary artery disease.
BACKGROUND: Although myocardial ischaemia monitored by some implantable cardioverter-defibrillators (ICDs) might improve patient care, the clinical usefulness of this technology has not yet been validated. OBJECTIVE: To investigate the potential impact of ICD-based ischaemia monitoring on clinical care and patient management of ICD recipients. DESIGN: Prospective, controlled, non-randomised study. SETTING: Single-centre, university hospital. PATIENTS: Consecutive patients with known coronary artery disease, followed up for at least 6 months. INTERVENTIONS: Patients implanted with either an ICD providing continuous intracardiac ST monitoring (n=53; ST group) or with an ICD without this capability (n=50). MAIN OUTCOME MEASURES: Major cardiovascular events, appropriateness of ST-shift episodes and unscheduled device-related visits. RESULTS: During follow-up (15.4±8.4 months), one patient experienced ST-shift events confirmed by angiography to be related to myocardial ischaemia. Myocardial infarction was a rare event and occurred in one patient (ST group) who had an ST-elevation myocardial infarction 3 weeks after the implant, but at this time the algorithm had not yet been activated. In the ST group, seven patients had one or more episodes of false-positive ST events (median 9, range 1-90). The programmable features of the device helped overcome the problem in six patients. Among patients with a remote monitoring system, unscheduled outpatient visits were significantly increased in the ST group (17 vs 4; p=0.032). CONCLUSIONS: Although, this study was underpowered by the small number of acute ischaemic events, ICD-based ST monitoring failed to provide a benefit over ICDs without this capability and increased unscheduled evaluations in patients with remote follow-up. The sensitivity and specificity of the algorithm still require validation.
No takes yet. Share an insight, caveat, or question.
Forleo et al. (2011) conducted an observational in coronary artery disease (n=103). ICD providing continuous intracardiac ST monitoring vs. ICD without continuous intracardiac ST monitoring was evaluated on Major cardiovascular events, appropriateness of ST-shift episodes and unscheduled device-related visits (p=0.032). Continuous intracardiac ST monitoring via ICD failed to provide clinical benefit over conventional ICDs and increased unscheduled outpatient visits.
Synapse has enriched 10 related papers. Consider them for comparative context: